These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 19411348

  • 1. Antidepressant switching among adherent patients treated for depression.
    Marcus SC, Hassan M, Olfson M.
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [Abstract] [Full Text] [Related]

  • 2. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 3. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK, Kruzikas DT, McLaughlin TP.
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [Abstract] [Full Text] [Related]

  • 4. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW.
    J Manag Care Pharm; 2006 Jun; 12(1):43-54. PubMed ID: 16420107
    [Abstract] [Full Text] [Related]

  • 5. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [Abstract] [Full Text] [Related]

  • 6. Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
    Zheng W, Zhang YF, Zhong HQ, Mai SM, Yang XH, Xiang YT.
    East Asian Arch Psychiatry; 2016 Sep; 26(3):87-97. PubMed ID: 27703096
    [Abstract] [Full Text] [Related]

  • 7. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
    Agius M, Gardner J, Liu K, Zaman R.
    Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
    [Abstract] [Full Text] [Related]

  • 8. An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
    Agius M, Gardner J, Liu K, Zaman R.
    Psychiatr Danub; 2010 Jun; 22(2):350-3. PubMed ID: 20562780
    [Abstract] [Full Text] [Related]

  • 9. Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
    Egberts AC, Lenderink AW, de Koning FH, Leufkens HG.
    J Clin Psychopharmacol; 1997 Jun; 17(3):149-55. PubMed ID: 9169957
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 11. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 12. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [Abstract] [Full Text] [Related]

  • 13. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 14. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB, Cunha FT, Salgado JV, Teixeira AL, Nicolato R.
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E, Kus K, Bobkiewicz-Kozłowska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [Abstract] [Full Text] [Related]

  • 16. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R.
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [Abstract] [Full Text] [Related]

  • 17. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
    Arnow BA, Blasey C, Williams LM, Palmer DM, Rekshan W, Schatzberg AF, Etkin A, Kulkarni J, Luther JF, Rush AJ.
    Am J Psychiatry; 2015 Aug 01; 172(8):743-50. PubMed ID: 25815419
    [Abstract] [Full Text] [Related]

  • 18. Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.
    Furukawa TA, Akechi T, Shimodera S, Yamada M, Miki K, Watanabe N, Inagaki M, Yonemoto N.
    Trials; 2011 May 11; 12():116. PubMed ID: 21569309
    [Abstract] [Full Text] [Related]

  • 19. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ, CO-MED Study Team.
    Eur Neuropsychopharmacol; 2012 Mar 11; 22(3):183-99. PubMed ID: 21920711
    [Abstract] [Full Text] [Related]

  • 20. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun 11; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.